Mintek invites Expressions of Interest from established healthcare, diagnostics, pharmaceutical and life-sciences companies, investors and strategic partners with the capability to commercialise and scale the SAHPRA-registered Phila•Test® HIV 1/2 Rapid Diagnostic Test across South Africa, Africa and international markets. The technology has been validated through clinical trials and is supported by regulatory compliant manufacturing infrastructure, with WHO prequalification currently under review. The opportunity is to establish a dedicated commercial venture with the capability to manufacture, market and distribute the Phila•Test® at scale.
Mintek is seeking a strategic partner to acquire a majority and controlling equity shareholding in the new venture and provide the capital and commercial capabilities required for scale-up and market expansion. Interested parties are invited to submit an EOI outlining their proposed majority equity participation, indicative investment, relevant market and distribution footprint, healthcare/diagnostics track record, and capacity to support manufacturing and commercial growth. Shortlisted parties will be invited to participate in the subsequent due diligence and transaction process.
The minimum items requested from the prospective partners are:
1. EOI proposal.
2. CSD Registration: Mandatory proof of active registration on the National Treasury Central Supplier Database (CSD) is required for all respondents or joint venture partners.
3. Tax Compliance: Valid tax clearance or proof of tax compliance status via SARS pin.
4. Company Documentation: Certified company registration documents, shareholder certificates.
5. Prescribed Submissions: Company or Investor profile, including the entity’s ownership structure, years of experience in the relevant industry or investment sector, and relevant investment or industry track record.
6. Sector Accreditations: Specific statutory or industry accreditations (such as SAHPRA if so required / FSCA in the case of an investor) depending on the project scope or how you envisage this equity deal to unfold.
Closing Date for submissions: 20 November 2026
Time: 12H00 SAST
Submissions must be directed to tenders@mintek.co.za
NB: No late submissions will be accepted.
Feedback to be provided to shortlisted respondents within six weeks for subsequent steps.
Queries relating to this EOI should be directed to thandiwem@mintek.co.za and Telephone: 011 709 4196.
